ROSE DIAGNOSTICS INC.
About ROSE DIAGNOSTICS INC.
ROSE Diagnostics Inc. was founded in California in 2023 to bridge pathology labs and cancer biopsy clinics with rapid point-of-care diagnostic testing. The company develops a panel of lymph node biomarkers in a rapid 5-minute test format using disposable cartridges for lung cancer biopsies. Its verifi LUNG test aims to reduce insufficient samples, which occur up to 40% of the time, enabling faster diagnosis and treatment. The team includes scientists, product developers, and regulatory experts with prior successful product launches in diagnostics.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Closed $2.3M Reg D financing in 2024 to fund product development and clinical trials.
- First patient enrolled in clinical study for verifi LUNG test with successful sample collection.
- Rapid 5-minute point-of-care test targets up to 40% insufficient lung biopsy samples.
- Founded in 2023 in Carlsbad, CA by diagnostics industry veterans.
Ask StreetZero about ROSE DIAGNOSTICS INC.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account